- CNBC•11 hours ago
Jim Cramer expects one group to return after the election, and provides his take on various caller stocks in the lightning round.
- Market Realist•12 hours ago
On October 21, 2016, Pfizer was trading at a forward PE multiple of about 11.4x. Since January 1, 2016, it has traded at PE multiples of 11.2x–13.5x.
- Market Realist•19 hours ago
On July 28, 2016, Pfizer announced positive results from the Phase 3 trial testing efficacy of Xeljanz as therapy for patients suffering with moderate to severely active ulcerative colitis (or UC).
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||31.97 x 200|
|Ask||32.79 x 200|
|Day's Range||32.15 - 32.60|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||28.72|
|Avg Vol (3m)||19,154,563|
|Dividend & Yield||1.20 (3.72%)|